Published in Psychother Psychosom on March 21, 2013
Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription. J Can Acad Child Adolesc Psychiatry (2013) 0.77
Antidepressants increase risk of behavioural symptoms in children and adolescents with depression or anxiety. Evid Based Ment Health (2013) 0.75
A Pilot Study of Safety and Efficacy of Cranial Electrotherapy Stimulation in Treatment of Bipolar II Depression. J Nerv Ment Dis (2015) 0.75
What's next for developmental psychiatry? World Psychiatry (2013) 0.75
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry (2004) 3.76
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry (2007) 3.40
International consensus study of antipsychotic dosing. Am J Psychiatry (2010) 3.39
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am J Psychiatry (2003) 3.00
Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry (2008) 2.44
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry (2010) 2.39
Long-term treatment with antidepressant drugs: the spectacular achievements of propaganda. Psychother Psychosom (2002) 2.11
Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom (2010) 2.08
Modern antipsychotic drugs: a critical overview. CMAJ (2005) 1.98
EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry (2002) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders. Am J Psychiatry (2003) 1.84
Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res (2005) 1.77
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom (2013) 1.73
The biopsychosocial model thirty years later. Psychother Psychosom (2007) 1.68
Inpatient antipsychotic drug use in 1998, 1993, and 1989. Am J Psychiatry (2002) 1.62
Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder. Harv Rev Psychiatry (2002) 1.60
Persistent psychological distress in patients treated for endocrine disease. Psychother Psychosom (2004) 1.51
Effects of newer antipsychotics on extrapyramidal function. CNS Drugs (2002) 1.50
ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology (2006) 1.49
Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation. Am J Psychiatry (2002) 1.49
Precursors of bipolar disorders: a systematic literature review of prospective studies. J Clin Psychiatry (2015) 1.49
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry (2007) 1.49
Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010. Psychother Psychosom (2013) 1.46
Effects of lithium on cognitive performance: a meta-analysis. J Clin Psychiatry (2009) 1.46
Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom (2014) 1.46
Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord (2009) 1.46
Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry (2004) 1.43
Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom (2013) 1.43
Integration of suicidology with general medicine: an obligation to society. Patient Educ Couns (2011) 1.42
Cognition and disability in bipolar disorder: lessons from schizophrenia research. Bipolar Disord (2010) 1.41
Disability and its treatment in bipolar disorder patients. Bipolar Disord (2007) 1.39
Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia. Int J Neuropsychopharmacol (2007) 1.39
Unmasking special interest groups: the key to addressing conflicts of interest in medicine. Psychother Psychosom (2010) 1.38
The biopsychosocial factor. Psychother Psychosom (2011) 1.38
Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev (2003) 1.36
Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord (2008) 1.35
Increasing psychological well-being and resilience by psychotherapeutic methods. J Pers (2009) 1.34
Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology (2010) 1.28
The concept of recovery in major depression. Psychol Med (2007) 1.27
Suicide risk and treatments for patients with bipolar disorder. JAMA (2003) 1.26
Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry (2006) 1.24
Suicide rates in relation to health care access in the United States: an ecological study. J Clin Psychiatry (2006) 1.22
Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord (2006) 1.18
Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology (2011) 1.18
Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry (2007) 1.17
The cult of mediocrity. Psychother Psychosom (2005) 1.15
Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry (2011) 1.14
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2008) 1.13
Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2007) 1.12
McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry (2010) 1.11
Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord (2004) 1.11
Advances in development of dopaminergic aporphinoids. J Med Chem (2007) 1.10
Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol (2013) 1.10
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord (2006) 1.08
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol (2006) 1.07
Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926. Harv Rev Psychiatry (2005) 1.06
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines. Eur J Pharmacol (2003) 1.06
Substance abuse in first-episode bipolar I disorder: indications for early intervention. Am J Psychiatry (2005) 1.04
Stressful life events, depression and demoralization as risk factors for acute coronary heart disease. Psychother Psychosom (2005) 1.04
Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev (2013) 1.03
Assessing demoralization and depression in the setting of medical disease. J Clin Psychiatry (2005) 1.03
Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry (2007) 0.99
Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2006) 0.98
Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients. Epidemiol Psichiatr Soc (2009) 0.98
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacology (Berl) (2002) 0.98
Staging of mental disorders: systematic review. Psychother Psychosom (2012) 0.98
Well-being therapy in school settings: a pilot study. Psychother Psychosom (2006) 0.97
Role of well-being therapy in achieving a balanced and individualized path to optimal functioning. Clin Psychol Psychother (2012) 0.97
Prophylaxis latency and outcome in bipolar disorders. Can J Psychiatry (2003) 0.97
The road to recovery from depression--don't drive today with yesterday's map. Psychother Psychosom (2007) 0.97
New modalities of assessment and treatment planning in depression: the sequential approach. CNS Drugs (2010) 0.97
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J Pharmacol Exp Ther (2002) 0.97
Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord (2005) 0.97
Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder. Bipolar Disord (2013) 0.96
Treatise on insanity in pregnant, postpartum, and lactating women (1858) by Louis-Victor Marcé: a commentary. Harv Rev Psychiatry (2009) 0.96
The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry (2011) 0.95
Factors associated with dropout from treatment for eating disorders: a comprehensive literature review. BMC Psychiatry (2009) 0.95
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects. Synapse (2006) 0.95
Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety (2010) 0.94
Mania associated with venlafaxine discontinuation. Int J Neuropsychopharmacol (2003) 0.94
Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol (2011) 0.93
Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology (2004) 0.93
Psychosomatic aspects of Cushing's syndrome. Rev Endocr Metab Disord (2010) 0.93
Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Chem Rev (2013) 0.92
Antipsychotic drug use: McLean Hospital, 2002. Hum Psychopharmacol (2005) 0.92
Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord (2008) 0.92
Factors associated with functional recovery in bipolar disorder patients. Bipolar Disord (2010) 0.92
Use of combinations of antipsychotics: McLean Hospital inpatients, 2002. Hum Psychopharmacol (2005) 0.92
Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice. J Mol Neurosci (2004) 0.92
Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord (2007) 0.91
School intervention for promoting psychological well-being in adolescence. J Behav Ther Exp Psychiatry (2009) 0.91
Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol (2006) 0.91
Well-being therapy for generalized anxiety disorder. J Clin Psychol (2009) 0.91
Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review. J Affect Disord (2004) 0.91
Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol (Oxf) (2007) 0.91
Suicidal risk factors in bipolar I and II disorder patients. J Clin Psychiatry (2011) 0.91
Dopamine D4 receptors: beyond schizophrenia. J Recept Signal Transduct Res (2004) 0.91